Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 355
mi
from
Shelby, NC
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 355
mi
from
Shelby, NC
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 337
mi
from
Oklahoma City, OK
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 337
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 345
mi
from
Johnston, RI
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 345
mi
from
Johnston, RI
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 362
mi
from
Providence, RI
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 362
mi
from
Providence, RI
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 343
mi
from
Spartanburg, SC
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 343
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 357
mi
from
Chattanooga, TN
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 357
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 365
mi
from
Austin, TX
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 365
mi
from
Austin, TX
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 09
mi
from
Houston, TX
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 09
mi
from
Houston, TX
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 359
mi
from
Pflugerville, TX
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 359
mi
from
Pflugerville, TX
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 339
mi
from
Plano, TX
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 339
mi
from
Plano, TX
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 361
mi
from
San Antonio, TX
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 361
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 351
mi
from
Draper, UT
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 351
mi
from
Draper, UT
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 342
mi
from
Norfolk, VA
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 342
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 16038
mi
from
Richmond, VA
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 16038
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 386
mi
from
Encinitas, CA
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 386
mi
from
Encinitas, CA
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 387
mi
from
Las Vegas, NV
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 387
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 382
mi
from
Anderson, SC
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 382
mi
from
Anderson, SC
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Study Site 383
mi
from
North Hollywood, CA
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
A Randomized, Double-Blind, Placebo Controlled Study Of The Efficacy, Safety, And Tolerability Of Serlopitant For The Treatment Of Pruritus In Adults And Adolescents With A History Of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Study Site 383
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
Birmingham, AL
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Fort Smith, AR
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Fort Smith, AR
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
Long Beach, CA
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
Los Angeles, CA
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Murrieta, CA
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Murrieta, CA
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Oceanside, CA
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Orange, CA
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Orange, CA
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Rolling Hills Estates, CA
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Santa Monica, CA
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Denver, CO
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Coral Gables, FL
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
Tampa, FL
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Normal, IL
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Normal, IL
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Skokie, IL
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Skokie, IL
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Indianapolis, IN
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Rockville, MD
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Plymouth, MN
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Saint Joseph, MO
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
Berlin, NJ
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Windsor, NJ
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Windsor, NJ
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Corning, NY
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Corning, NY
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Forest Hills, NY
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Forest Hills, NY
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
New York, NY
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
New York, NY
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
High Point, NC
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
High Point, NC
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
Raleigh, NC
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
Tulsa, OK
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
Tulsa, OK
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Portland, OR
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
Charleston, SC
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Greer, SC
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Greer, SC
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site
mi
from
Bellaire, TX
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site
mi
from
Bellaire, TX
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Investigational Site 1
mi
from
Fort Worth, TX
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Investigational Site 1
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regeneron Study Site
mi
from
San Antonio, TX
Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis
An Open-label, Randomized, Actual Use Study of Dupilumab Auto-injector Device in Patients With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regeneron Study Site
mi
from
San Antonio, TX
Click here to add this to my saved trials